Skip to main content

Find Clinical Trials

Home
Conditions
Glomerulonephritis

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

521 public trials 167 recruiting studies

Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

NCT06527872

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

GSK Investigational Site Charlotte, North Carolina, United States

GSK Investigational Site Columbus, Ohio, United States

GSK Investigational Site Hixson, Tennessee, United States

View Trial Details

Recruiting

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

NCT07010250

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +31 more
Locations: Georges-Pompidou European Hospital, AP-HP Paris, France

View Trial Details

Recruiting

Biomarker Development for Autoimmune Disorders Involving the Kidneys

NCT07666711

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations: Oslo universitetssykehus HF, Rikshospitalet, Clinic for Surgery and Specialized Medicine, Department of Rheumatology, Skin and Infectious Diseases Oslo, Norway

View Trial Details

Recruiting

A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy

NCT07416162

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +23 more
Locations: Novartis Investigative Site Jeollanam, South Korea

Novartis Investigative Site Seoul, South Korea

Novartis Investigative Site Seoul, South Korea

View Trial Details

Recruiting

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

NCT06926244

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Nephrology department, Hospital Pitié - Salpêtrière (ASSISTANCE PUBLIQUE HOPITAUX DE PARIS AP-HP) Paris, France

View Trial Details

Recruiting

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

NCT06341205

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: CHU de BESANCON Besançon, France

CHU de BORDEAUX - Hôpital Pellegrin Bordeaux, France

CHU de CAEN Caen, France

AP-HP - Hôpital H. Mondor Créteil, France

View all 14 locations

View Trial Details

Recruiting

Immunopathological Analysis in a French National Cohort of Membranous Nephropathy

NCT04326218

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: CHU de Nice, Hôpital de l'Archet Nice, Alpes Maritime, France

View Trial Details

Recruiting

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

NCT06676631

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdomg, China

View Trial Details

Recruiting

US Zamto-cel Autoimmune Diseases

NCT06708845

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +17 more
Locations: Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

NEPTUNE Match Study

NCT04571658

Conditions: Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +29 more
Locations: Emory University Hospital - Children's Hospital of Atlanta Atlanta, Georgia, United States

John H. Stroger, Jr., Hospital of Cook County Chicago, Illinois, United States

University of Kansas Medical Center Kansas City, Kansas, United States

Johns Hopkins Medicine Baltimore, Maryland, United States

View all 16 locations

View Trial Details